Skip to main content
Watch Insiders
JNJHealthcare

Johnson & Johnson (JNJ) Insider Trading

In the last 90 days, 4 Johnson & Johnson (JNJ) insiders reported no open-market purchases and 5 sales totaling $61,986,732. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 2, 2026Timothy SchmidEVP, WW Chair, MedTechSale33,597$274.74$9,230,440
Aug 17, 2026Jennifer L TaubertEVP, WWC. Innovative MedicineSale15,000$263.36$3,950,400
Aug 13, 2026Joaquin DuatoCEO and Chairman of the BoardSale123,291$261.17$32,199,923
Aug 6, 2026Elizabeth ForminardEVP, Chief Legal OfficerSale15,918$257.00$4,090,959
Aug 5, 2026Joaquin DuatoCEO and Chairman of the BoardSale48,480$258.15$12,515,010
Jul 20, 2026Vanessa BroadhurstEVP, Global Corp AffairsSale23,054$251.27$5,792,686
Jun 11, 2026Kathryn E WengelEVP, Chief TO and Risk OfficerSale10,000$241.15$2,411,500

Common questions

JNJ insider trading FAQ

Are JNJ insiders buying or selling?
Over the last 90 days, JNJ insiders were net sellers, reporting $0.00 of open-market purchases and $61,986,732 of sales.
When was the last JNJ insider purchase?
No open-market insider purchase of Johnson & Johnson stock was reported in the last 90 days.
Where does JNJ insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Johnson & Johnson officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.